Quantessence Capital’s Patterson-UTI PTEN Stock Holding History

Quantessence Capital’s Portfolio PTEN Stock Details PTEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-72,700	Closed	-$598K	–	386
2025 Q1	$598K	Buy	+72,700	New	+$610K	0.15%	173

Other funds holding PTEN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Sourcerock Group Denver, Colorado $2.48B AUM 72.25% 1-Year Est. Return

AIM

ARGA Investment Management Stamford, Connecticut $3.05B AUM 47.96% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Quantessence Capital's PTEN Position: Q2 2025 in Review

Quantessence Capital sold out of Patterson-UTI (PTEN) in Q2 2025, closing a stake of 72,700 shares — an estimated $598K sold.

Quantessence Capital first reported a position in PTEN in Q1 2025 and held it in 1 quarter. The position peaked at $598K in Q1 2025. 361 funds tracked by Wall St. Rank hold PTEN as of Q2 2025.

Quantessence Capital reported no remaining Patterson-UTI position as of Q2 2025 after selling out during the quarter.
Quantessence Capital sold 72,700 Patterson-UTI shares in Q2 2025, an estimated $598K.
Quantessence Capital first reported a position in Patterson-UTI in Q1 2025 and held it in 1 quarter.
Quantessence Capital's Patterson-UTI position peaked at $598K in Q1 2025.
361 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2025.

Based on Quantessence Capital's 13F filing for Q2 2025, filed 14 Aug 2025.